Insmed Incorporated
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersBridgewater, NJ
SAM.gov UEIGLE1HZQ47JW6
Insmed is a biopharmaceutical company that develops therapies using scientific approaches including gene therapy with targeted delivery, protein deimmunization, RNA end-joining, and synthetic rescue. The company markets therapies named ARIKAYCE and BRINSUPRI, and conducts clinical trials. Insmed serves patients across disease areas and operates globally in the U.S., Japan, and Europe.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Insmed Incorporated | Bridgewater | NJ | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.